Healthcare -
Biotechnology - NASDAQ - CH
$ 42.15
0.262 %
$ 3.6 B
Market Cap
-15.11
P/E
Price Target
Average
75.22%
Revenue Forecast
Estimate
65.81%
EBIT
Estimate
--45.58%
Net Income
Estimate
42.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
CRISPR Therapeutics AG
Wall Street analysts predict an average 1-year price target for CRSP of $73.9 , with forecasts ranging from
a
low of
$52 to a high of $100 .
CRSP Lowest Price Target
Wall Street Target
52 USD
23.37%
CRSP Average Price Target
Wall Street Target
73.9 USD
75.22%
CRSP Highest Price Target
Wall Street Target
100 USD
137.25%
REVENUE FORECAST
Revenue Forecast Chart CRSP
EBIT FORECAST
EBIT Forecast Chart CRSP
NET INCOME FORECAST
Net Income Chart CRSP